Therma Bright Inc

XTSX:THRM

Therma Bright, Inc. develops and markets skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is a developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other diagnostic and medical device technologies that help test for illnesses and assist with pain management. The firm is focused on providing consumers and medical professionals with solutions that addresses medical and healthcare challenges. The company also provides a technology that delivers non-invasive, and pain-free skincare. Its product offerings include AcuVid, which is an antigen and antibody rapid screening test for COVID-19; Venowave, is a Deep Vein Thrombosis (DVT) prevention pump specifically designed for use at home; InterceptCS, is a system that provides controlled topical heat without the risk of burning the skin; Benepod, is a hot and cold contrast therapy device for pain relief without pain relieving medication, and TherOZap, provides pain management relief using thermal therapy for insect bites and stings.